TY - CONF T1 - LABORATORY SAFETY OF DUPILUMAB IN PEDIATRIC PATIENTS AGED >= 6-< 12 YEARS WITH SEVERE ATOPIC DERMATITIS: RESULTS FROM A PHASE 3 TRIAL (LIBERTY AD PEDS) JO - ACTA DERMATO-VENEREOLOGICA PY - 2021/01/01 AU - Wollenberg A AU - Thaci D AU - Cork MJ AU - Arkwright PD AU - Gooderham M AU - Sun X AU - O'Malley JT AU - Khokhar FA AU - Bansal A AU - Shumel B ED - VL - 101 SP - 59 EP - 59 Y2 - 2025/08/13 ER -